Biopsy Archives | Surviving Mesothelioma

Thoracoscopy Deemed “Valuable and Safe” for Mesothelioma Patients

Pleural mesothelioma patients who are recommended for medical thoracoscopy can rest assured that the procedure is “a valuable and safe” diagnostic tool. That is the message from Chinese researchers after an analysis of nine years of medical thoracoscopies on more than 800 patients with malignant mesothelioma and other pleural cancers at a Beijing hospital. What is Medical Thoracoscopy? Medical thoracoscopy is a minimally invasive procedure … Continue reading Thoracoscopy Deemed “Valuable and Safe” for Mesothelioma Patients »

New Mesothelioma Study: Asbestos Fiber Burden Does Not Decline With Time

Mesothelioma has one of the longest latency periods of any disease. It is not unusual for patients to develop the asbestos cancer many decades after their last exposure to asbestos. Now, a new German study offers a more detailed explanation of why that is. Although the body is adept at ridding itself of many kinds of toxins, when asbestos fibers are inhaled or swallowed, their … Continue reading New Mesothelioma Study: Asbestos Fiber Burden Does Not Decline With Time »

Cellular Factors Predict Survival in Epithelioid Mesothelioma Patients

A team of French scientists believe they have found a way to predict survival and help plan a treatment course for people with the epithelioid form of malignant pleural mesothelioma. Until now, mesothelioma histological subtype has been the only way to reliably predict mesothelioma prognosis based on pathology (cellular characteristics that can be seen under a microscope). But mesothelioma researchers at the University Hospital of … Continue reading Cellular Factors Predict Survival in Epithelioid Mesothelioma Patients »

Mesothelioma Diagnosis: Fluid Cytology Versus Biopsy

A mesothelioma diagnosis using pleural fluid is just as reliable at predicting survival as a diagnosis based on a tissue sample. That conclusion, published in a recent issue of the British Journal of Cancer, is based on an analysis of more than 2,000 cases of malignant mesothelioma over 42 years. Researchers from the University of Western Australia and Curtin University in Perth compared the survival … Continue reading Mesothelioma Diagnosis: Fluid Cytology Versus Biopsy »

New Mesothelioma Grading System May Lead to More Accurate Prognosis

A new method for determining the prognosis of people with peritoneal mesothelioma suggests that patients whose mesothelioma cells have certain characteristics may live as long as 12 years. A research team including scientists from Wake Forest Baptist Health in North Carolina, the University of Mississippi Medical Center, and Memorial Sloan Kettering Cancer Center in New York has developed the first two-tier grading system for malignant … Continue reading New Mesothelioma Grading System May Lead to More Accurate Prognosis »

Mesothelioma Subtype Unrelated to Source or Degree of Asbestos Exposure

The source or degree of a mesothelioma patient’s asbestos exposure does not appear to have a direct impact on what mesothelioma subtype they develop. That is according to the results of a newly-published study out of Australia, a country with one of the world’s highest rates of asbestos cancer. To make their determination, mesothelioma researchers reviewed malignant mesothelioma cases from the Western Australian Mesothelioma Registry … Continue reading Mesothelioma Subtype Unrelated to Source or Degree of Asbestos Exposure »

Diagnosing Mesothelioma with Medical Thoracoscopy

Medical thoracoscopy, a procedure used to diagnose and treat pleural diseases such as malignant pleural mesothelioma, provides the information needed to make a diagnosis in about 80 percent of patients. That is up by more than 20 percent in the last three decades. In a newly published study, a team of Italian pulmonary medicine specialists say the procedure, which is also known as pleuroscopy, has … Continue reading Diagnosing Mesothelioma with Medical Thoracoscopy »

Most Mesothelioma Patients Don’t Need Preventive Radiotherapy after Pleural Intervention

Preventive radiotherapy may not be the best way to keep new tumors from growing at the site of pleural interventions in people with malignant pleural mesothelioma. That is the finding of a group of physician researchers in the UK, who tracked the outcomes of more than 200 mesothelioma patients from institutes across the country who had procedures that required the use of a large-bore pleural … Continue reading Most Mesothelioma Patients Don’t Need Preventive Radiotherapy after Pleural Intervention »

Preventing New Tumor “Seeding” After Mesothelioma Biopsy

Doctors in England are testing a method they hope will reduce the likelihood of pleural mesothelioma patients developing new tumors in their chest wall after a biopsy. A tissue sample is required to make a definitive mesothelioma diagnosis. But as many as 15 percent of mesothelioma patients who undergo some kind of invasive biopsy procedure will develop tiny new tumors along the tracks of the … Continue reading Preventing New Tumor “Seeding” After Mesothelioma Biopsy »

The Challenge of Diagnosing Malignant Mesothelioma

The case of a Japanese man whose mesothelioma went undetected until it claimed his life seven months later highlights the need for better and earlier mesothelioma diagnosis. The man is the subject of a new article published in the medical journal Case Reports in Oncology. Although the patient complained of chest pain for months, his doctors were never able to make a diagnosis of mesothelioma. … Continue reading The Challenge of Diagnosing Malignant Mesothelioma »

Get your free copy of
“Surviving Mesothelioma” Today!